Baiyunshan and Zhongnanshan research on isatis root, which is expected to be developed into a new antiviral drug

After the closing of the market on February 2, Baiyunshan's Li Jiacheng joint venture Baiyunshan and Huang announced in the First Affiliated Hospital of Guangzhou Medical University where Zhong Nanshan is located that the research team led by academician Zhong Nanshan has confirmed that Baiyunshan isatis root can be multi-target and multi-channel antivirus, and a new antiviral component isolated from Isatis root has been successfully synthesized and is expected to be developed into Antiviral drugs Baiyun Mountain of Guangyao disclosed the above information yesterday at the Second Council of "yueao Joint Research Center for respiratory pathogens" and the anti viral research seminar of Baiyun Mountain Banlangen Granules It is understood that since 2008, led by the State Key Laboratory of respiratory diseases of Guangzhou Medical University and Baiyunshan and Huang, it has successively integrated the State Key Laboratory of traditional Chinese medicine quality research of Macao University of science and technology, Fuzhou University, East China University of science and technology, Guangzhou Institute of medicine and biological health of Chinese Academy of Sciences, Guangdong entry exit inspection and Quarantine Center B SL-3 biosafety laboratory and other units jointly tackle key problems to conduct a more comprehensive clinical evidence-based and basic research on isatis root In 2010, Guangzhou Institute of respiratory diseases of Guangzhou Medical University, Baiyunshan group of Guangyao and Macao University of science and technology jointly established the "joint research center of respiratory pathogens in Guangdong and Macao" In 2011, the long-term cooperation mechanism between Guangdong and Macao continued to promote the basic and clinical research of Banlangen The joint research team introduced the international advanced concepts of "evidence-based medicine" and "system biology", implemented the strategy of clinical evidence-based and basic research in parallel, and found that the antiviral effect of Baiyunshan Banlangen fully reflected the characteristics of multi-target and multi-channel coordination of traditional Chinese medicine A new indole compound was isolated from Banlangen by Zhu Quan, Professor of Macao University of science and technology, a member of the joint research team The experiment proved that it has the effect of inhibiting the inflammatory reaction mediated by influenza virus, and it was synthesized by Dr Hu Wenhui, National Key Laboratory of respiratory diseases, which indicated that the antiviral component in Banlangen Granules of Baiyunshan has further development Potential for new drugs Zhong Nanshan said yesterday that the value of isatis root lies in its early discovery and early treatment The research project has been going through for more than three years, and the overall progress is smooth "In this study, the concept of system biology and multi-target was introduced Not for one chlamydia, but for the whole body Banlangen's research is to make a model We hope to be a model for the modernization of traditional Chinese medicine At present, clinical randomized double-blind experiments have been carried out " That's what Zhong Nanshan said According to Chen Mao, general manager of Baiyunshan Guangyao, the patent application for the synthetic antiviral ingredient discovered in this study has been authorized According to its introduction, Baiyunshan's ongoing 10 billion yuan financing plan is advancing in an orderly manner After the financing funds are in place, Baiyunshan's investment in R & D is expected to reach 1.5 billion yuan.